In RRP, serologic response to HPV is frequently absent and slow to develop
Published 2020 View Full Article
- Home
- Publications
- Publication Search
- Publication Details
Title
In RRP, serologic response to HPV is frequently absent and slow to develop
Authors
Keywords
Vaccines, HPV-6, Human papillomavirus infection, HPV-11, Papillomas, Antibodies, Serology, Vaccination and immunization
Journal
PLoS One
Volume 15, Issue 3, Pages e0230106
Publisher
Public Library of Science (PLoS)
Online
2020-03-12
DOI
10.1371/journal.pone.0230106
References
Ask authors/readers for more resources
Related references
Note: Only part of the references are listed.- Multi‐Year Effect of Human Papillomavirus Vaccination on Recurrent Respiratory Papillomatosis
- (2019) Hiroumi Matsuzaki et al. LARYNGOSCOPE
- A retrospective case-control analysis of the efficacy of Gardasil® vaccination in 28 patients with recurrent respiratory papillomatosis of the larynx
- (2018) T.D. Milner et al. CLINICAL OTOLARYNGOLOGY
- HPV vaccination as preventive approach for recurrent respiratory papillomatosis - a 22-year retrospective clinical analysis
- (2018) Paul Stefan Mauz et al. BMC INFECTIOUS DISEASES
- Treatment outcomes of recurrent respiratory papillomatosis
- (2017) V.-A. Papaioannou et al. HNO
- Gardasil Vaccination for Recurrent Laryngeal Papillomatosis in Adult Men
- (2017) Kiyoshi Makiyama et al. JOURNAL OF VOICE
- Final efficacy, immunogenicity, and safety analyses of a nine-valent human papillomavirus vaccine in women aged 16–26 years: a randomised, double-blind trial
- (2017) Warner K Huh et al. LANCET
- Multimodal treatment of a dog with disseminated cutaneous viral papillomatosis
- (2017) Britt J. Levy et al. VETERINARY DERMATOLOGY
- Impact of human papillomavirus (HPV) 16 and 18 vaccination on prevalent infections and rates of cervical lesions after excisional treatment
- (2016) Allan Hildesheim et al. AMERICAN JOURNAL OF OBSTETRICS AND GYNECOLOGY
- Immunological response to quadrivalent HPV vaccine in treatment of recurrent respiratory papillomatosis
- (2016) Robin E. A. Tjon Pian Gi et al. EUROPEAN ARCHIVES OF OTO-RHINO-LARYNGOLOGY
- Effectiveness of the human papillomavirus (types 6, 11, 16, and 18) vaccine in the treatment of children with recurrent respiratory papillomatosis
- (2016) Juliana Sato Hermann et al. INTERNATIONAL JOURNAL OF PEDIATRIC OTORHINOLARYNGOLOGY
- The Use of the Quadrivalent Human Papillomavirus Vaccine (Gardasil) as Adjuvant Therapy in the Treatment of Recurrent Respiratory Papilloma
- (2015) David L. Young et al. JOURNAL OF VOICE
- Human papilloma virus vaccination in patients with an aggressive course of recurrent respiratory papillomatosis
- (2014) Irena Hočevar-Boltežar et al. EUROPEAN ARCHIVES OF OTO-RHINO-LARYNGOLOGY
- Impact of the Quadrivalent HPV Vaccine on Disease Recurrence in Men Exposed to HPV Infection: A Randomized Study
- (2014) Enis Rauf Coskuner et al. Journal of Sexual Medicine
- In Vivo Mechanisms of Vaccine-Induced Protection against HPV Infection
- (2010) Patricia M. Day et al. Cell Host & Microbe
- Evolution of type-specific immunoassays to evaluate the functional immune response to GARDASIL®, a vaccine for Human Papillomavirus types 16, 18, 6, and 11
- (2010) Judith F. Smith et al. Human vaccines & immunotherapeutics
- Detection of Anti-HPV11-L1 Antibodies in Immune Sera from Patients Suffering from Recurrent Respiratory Papillomatosis Using ELISA
- (2010) Julia Durzyńska et al. VIRAL IMMUNOLOGY
- Age of Child, More than HPV Type, Is Associated with Clinical Course in Recurrent Respiratory Papillomatosis
- (2008) Farrel J. Buchinsky et al. PLoS One
Discover Peeref hubs
Discuss science. Find collaborators. Network.
Join a conversationFind the ideal target journal for your manuscript
Explore over 38,000 international journals covering a vast array of academic fields.
Search